4.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Galectin Therapeutics Inc Borsa (GALT) Ultime notizie
What MACD and RSI say about Galectin Therapeutics Inc.Weekly Stock Summary & Consistent Income Trade Recommendations - Newser
Should you wait for a breakout in Galectin Therapeutics Inc.July 2025 Selloffs & Reliable Trade Execution Plans - Newser
Relative strength of Galectin Therapeutics Inc. in sector analysisTrade Ideas & AI Optimized Trading Strategy Guides - Newser
Will Galectin Therapeutics Inc. benefit from macro trendsQuarterly Portfolio Report & Fast Momentum Entry Tips - Newser
Is Galectin Therapeutics Inc. trending in predictive chart modelsJuly 2025 Catalysts & Community Consensus Stock Picks - Newser
Will Galectin Therapeutics Inc. see short term momentumJuly 2025 Reactions & Safe Capital Growth Plans - Newser
Is Galectin Therapeutics Inc. a candidate for recovery playJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Will Galectin Therapeutics Inc. stock go up soonPortfolio Risk Summary & Accurate Trade Setup Notifications - Newser
Can Galectin Therapeutics Inc. recover in the next quarterInsider Selling & AI Forecasted Stock Moves - Newser
What’s next for Galectin Therapeutics Inc. stock priceWeekly Volume Report & Community Shared Stock Ideas - Newser
Galectin Therapeutics Inc. stock volume spike explainedMarket Trend Review & Weekly Momentum Stock Picks - Newser
Galectin: With Time Ticking, A Partner Is Needed To Revitalize MASH Program - Seeking Alpha
Does Galectin Therapeutics Inc. show high probability of rebound2025 Momentum Check & Daily Stock Trend Reports - Newser
Using Bollinger Bands to evaluate Galectin Therapeutics Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - Newser
Earnings visualization tools for Galectin Therapeutics Inc.July 2025 Macro Moves & Advanced Technical Signal Analysis - Newser
Is Galectin Therapeutics Inc. meeting your algorithmic filter criteriaNew Guidance & AI Powered Market Trend Analysis - Newser
Is Galectin Therapeutics Inc. on track to beat earningsJuly 2025 Institutional & Stepwise Trade Signal Guides - sundaytimes.kr
Galectin Therapeutics Inc. Stock Recovery Path — Analyst BreakdownQuarterly Risk Review & Daily Stock Trend Watchlist - beatles.ru
What is the earnings history of Galectin Therapeutics Inc.Stock Surge & Detailed Earnings Play Alerts - theviewers.co.kr
Investment Review: What is the dividend yield of Galectin Therapeutics Inc.Day Trade & Fast Entry and Exit Trade Plans - theviewers.co.kr
Quantitative breakdown of Galectin Therapeutics Inc. recent moveEarnings Trend Report & Long Hold Capital Preservation Plans - Newser
why galectin therapeutics inc. stock attracts strong analyst attentionJuly 2025 PostEarnings & Verified Chart Pattern Signals - Newser
Will Galectin Therapeutics Inc. stock recover after recent dropJuly 2025 Breakouts & High Conviction Trade Alerts - Newser
Using Bollinger Bands to evaluate Galectin Therapeutics Inc2025 Price Targets & Verified Chart Pattern Signals - Newser
Does Galectin Therapeutics Inc. stock have upside surprise potentialWeekly Risk Report & Advanced Technical Analysis Signals - sundaytimes.kr
What is HC Wainwright's Forecast for GALT Q3 Earnings? - MarketBeat
Intraday Charts Show Spike in Galectin Therapeutics Inc. Activity2025 Market Sentiment & Verified Chart Pattern Trade Signals - beatles.ru
What’s the profit margin of Galectin Therapeutics Inc.Earnings Summary Report & Expert Verified Movement Alerts - theviewers.co.kr
Galectin Therapeutics Inc. stock retracement – recovery analysisQuarterly Portfolio Review & Precise Trade Entry Recommendations - Newser
Galectin Therapeutics Inc. Included in Top Momentum ScanJuly 2025 Drop Watch & Low Drawdown Investment Strategies - Newser
Galectin Therapeutics (NASDAQ:GALT) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
Comparing Galectin Therapeutics Inc. in custom built stock radarsJuly 2025 Setups & High Accuracy Investment Signals - Newser
Galectin Therapeutics (NASDAQ:GALT) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Earns Buy Rating from HC Wainwright - MarketBeat
Galectin Therapeutics : Corporate Presentation, August 2025 - MarketScreener
How Galectin Therapeutics Inc. stock performs during market volatilityTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - Newser
Technical analysis overview for Galectin Therapeutics Inc. stockJuly 2025 Intraday Action & Growth Oriented Trade Recommendations - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):